Evidence-based interventions for cancer treatment–related mucositis: Putting evidence into practice

Clinical Journal of Oncology Nursing

Volumn 18, Issue 6, 2015, Pages 80-96

  Eilers, June ^a   Harris, Debra ^b   Henry, Karen ^c   Johnson, Lee Ann ^d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d ONCOLOGY NURSING SOCIETY   (United States)

Author keywords

Cancer related treatment; Evidence based practice; Mucositis; Nursing management; Oral cavity

Indexed keywords

EVIDENCE BASED NURSING; HUMAN; MUCOSITIS; NEOPLASMS; NURSING;

EVIDENCE-BASED NURSING; HUMANS; MUCOSITIS; NEOPLASMS;

EID: 84923769898     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/14.cjon.s3.80-96     Document Type: Article

References (195)

1. Abdulrhman, M., Elbarbary, N.S., Ahmed Amin, D., & Saeid Ebrahim, R. (2012). Honey and a mixture of honey, beeswax, and olive oil-propolis extract in treatment of chemotherapy-induced oral mucositis: A randomized controlled pilot study. Pediatric Hematology and Oncology, 29, 285–292. doi:10.3109/08880018.2012.669026.
2. Aisa, Y., Mori, T., Kudo, M., Yashima, T., Kondo, S., Yokoyama, A., Okamoto, S. (2005). Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer, 13, 266–269. doi:10.1007/s00520-004-0726-y.
3. Alterio, D., Jereczek-Fossa, B.A., Zuccotti, G.F., Leon, M.E., Omodeo Sale, E.O., Pasetti, M., Orecchia, R. (2006). Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study. International Journal of Radiation Oncology, Biology, Physics, 64, 392–395. doi:10.1016/j.ijrobp.2005.07.301.
4. Antonadou, D., Pepelassi, M., Synodinou, M., Puglisi, M., & Throuvalas, N. (2002). Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 52, 739–747. doi:10.1016/S0360-3016(01)02683-9.
5. Antunes, H.S., Ferreira, E.M., de Matos, V.D., Pinheiro, C.T., & Ferreira, C.G. (2008). The impact of low power laser in the treatment of conditioning-induced oral mucositis: A report of 11 clinical cases and their review. Medicina Oral, Patología Oral y Cirugía Bucal, 13, 189–192.
6. Antunes, H.S., Herchenhorn, D., Small, I.A., Araújo, C.M., Viégas, C.M., Cabral, E., Ferreira, C.G. (2013). Phase III trial of lowlevel laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiotherapy and Oncology, 109, 297–302. doi:10.1016/j.radonc.2013.08.010.
7. Arbabi-Kalati, F., Arbabi-Kalati, F., Deghatipour, M., & Ansari Moghadam, A. (2012). Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A doubleblind randomized clinical trial. Archives of Iranian Medicine, 15, 413–417. doi:012157/AIM.008.
8. Arbabi-Kalati, F., Arbabi-Kalati, F., & Moridi, T. (2013). Evaluation of the effect of low level laser on prevention of chemotherapyinduced mucositis. Acta Medica Iranica, 51, 157–162.
9. Arora, H., Pai, K.M., Maiya, A., Vidyasagar, M.S., & Rajeev, A. (2008). Efficacy of He-Ne laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 105, 180–186. doi:10.1016/j.tripleo.2007.07.043.
10. Awidi, A., Homsi, U., Kakail, R.I., Mubarak, A., Hassan, A., Kelta, M., El-Alossy, A.S. (2001). Double-blind, placebo-controlled crossover study of oral pilocarpine for the prevention of chemotherapyinduced oral mucositis in adult patients with cancer. European Journal of Cancer, 37, 2010–2014. doi:10.1016/S0959-8049(01)00189-7.
11. Babaee, N., Moslemi, D., Khalilpour, M., Vejdani, F., Moghadamnia, Y., Bijani, A., Moghadamnia, A.A. (2013). Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngeal mucositis in patients with head and neck cancers: A randomized controlled clinical study. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 21, 18. doi:10.1186/2008-2231-21-18.
12. Barasch, A., & Peterson, D.E. (2003). Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncology, 39, 91–100. doi:10.1016/S1368-8375(02)00033-7.
13. Barber, C., Powell, R., Ellis, A., & Hewett, J. (2007). Comparing pain control and ability to eat and drink with standard therapy vs. Gelclair: A preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Supportive Care in Cancer, 15, 427–440. doi:10.1007/s00520-006-0171-1.
14. Bardy, J., Molassiotis, A., Ryder, W.D., Mais, K., Sykes, A., Yap, B., Slevin, N. (2012). A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. British Journal of Oral and Maxillofacial Surgery, 50, 221–226. doi:10.1016/j.bjoms.2011.03.005.
15. ® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients. Future Oncology, 9, 1727–1732. doi:10.2217/fon.13.164.
16. Bhatt, V., Vendrell, N., Nau, K., Crumb, D., & Roy, V. (2010). Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation. Journal of Oncology Pharmacy Practice, 16, 195–204. doi:10.1177/1078155209348721.
17. Bjordal, J.M., Bensadoun, R.J., Tunèr, J., Frigo, L., Gjerde, K., & Lopes-Martins, R.A. (2011). A systematic review with metaanalysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Supportive Care in Cancer, 19, 1069–1077. doi:10.1007/s00520-011-1202-0.
18. Blijlevens, N., de Château, M., Krivan, G., Rabitsch, W., Szomor, A., Pytlik, R., Niederwieser, D. (2013). In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden. Bone Marrow Transplantation, 48, 966–971. doi:10.1038/bmt.2012.257.
19. Blijlevens, N.M., Donnelly, J.P., Naber, A.H., Schattenberg, A.V., & DePauw, B.E. (2005). A randomised, double-blinded, placebocontrolled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients. Supportive Care in Cancer, 13, 790–796. doi:10.1007/s00520-005-0790-y.
20. ®): A bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions. Expert Opinion on Drug Metabolism and Toxicology, 4, 1449–1454. doi:10.1517/17425250802525371.
21. Buentzel, J., Micke, O., Adamietz, I.A., Monnier, A., Glatzel, M., & deVries, A. (2006). Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebocontrolled phase III study. International Journal of Radiation Oncology, Biology, Physics, 64, 684–691. doi:10.1016/j.ijrobp.2005.08.005.
22. Caplinger, J., Royse, M., & Martens, J. (2010). Implementation of an oral care protocol to promote early detection and management of stomatitis. Clinical Journal of Oncology Nursing, 14, 799–802. doi:10.1188/10.CJON.799-802.
23. Carlotto, A., Hogsett, V.L., Maiorini, E.M., Razulis, J.G., & Sonis, S.T. (2013). The economic burden of toxicities associated with cancer treatment: Review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics, 31, 753–766. doi:10.1007/s40273-013-0081-2.
24. Carulli, G., Rocco, M., Panichi, A., Chios, C.F., Ciurli, E., Mannucci, C., Petrini, M. (2013). Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: A prospective, randomized study with a mouthwash containing cameliasinensis leaf extract. Hematology Reports, 5, 21–25. doi:10.4081/hr.2013.e6.
25. Carvalho, P.A., Jaguar, G.C., Pellizzon, A.C., Prado, J.D., Lopes, R.N., & Alves, F.A. (2011). Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: A doubleblind randomized study in head and neck cancer patients. Oral Oncology, 47, 1176–1181. doi:10.1016/j.oraloncology.2011.08.021.
26. Castagna, L., Benhamou, E., Pedraza, E., Luboinski, M., Forni, M., Brandes, I., Dietrich, P.Y. (2001). Prevention of mucositis in bone marrow transplantation: A double blind randomized controlled trial of sucralfate. Annals of Oncology, 12, 953–955. doi:10.1023/A:1011119721267.
27. Cauwels, R.G., & Martens, L.C. (2011). Low level laser therapy in oral mucositis: A pilot study. European Archives of Paediatric Dentistry, 12, 118–123. doi:10.1007/BF03262791.
28. Cawford, J., Tomita, D.K., Mazanet, R., Glaspy, J., & Ozer, H. (1999). Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy. Cytokines, Cellular and Molecular Therapy, 5, 187–193.
29. Cerchietti, L.C., Navigante, A.H., Lutteral, M.A., Castro, M.A., Kirchuck, R., Bonomi, M., Uchima, P. (2006). Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 65, 1330–1337. doi:10.1016/j.ijrobp.2006.03.042.
30. Chermetz, M., Gobbo, M., Ronfani, L., Ottaviani, G., Zanazzo, G.A., Verzegnassi, F., Zacchigna, S. (2013). Class IV laser therapy as treatment for chemotherapy-induced oral mucositis in oncohaematological paediatric patients: A prospective study. International Journal of Paediatric Dentistry. Advanced online publication. doi:10.1111/ipd.12090.
31. Cheng, K.K., Chang, A.M., & Yuen, M.P. (2004). Prevention of oral mucositis in pediatric patients treated with chemotherapy: A randomized crossover trial comparing two protocols of oral care. European Journal of Cancer, 40, 1208–1216. doi:10.1016/j.ejca.2003.10.023.
32. Cheng, K.K., Molassiotis, A., Chang, A.M., Wai, W.C., & Cheung, S.S. (2001). Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in pediatric cancer patients. European Journal of Cancer, 37, 2056–2063. doi:10.1016/S0959-8049(01)00098-3.
33. Clarkson, J.E., Worthington, H.V., Furness, S., McCabe, M., Khalid, T., & Meyer, S. (2010). Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, 8, CD001973. doi:10.1002/14651858.CD001973.pub4.
34. Colella, G., Cannavale, R., Vicidomini, A., Rinaldi, G., Compilato, D., & Campisi, G. (2010). Efficacy of a spray compound containing a pool of collagen precursor synthetic aminoacids (l-proline, l-leucine, l-lysine and glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis: Preliminary data of an open trial. International Journal of Immunopathology and Pharmacology, 23, 143–151.
35. Cruz, L.B., Ribeiro, A.S., Rech, A., Rosa, L.G., Castro, C.G., & Brunetto, A.L. (2007). Inf luence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatric Blood and Cancer, 48, 435–440. doi:10.1002/pbc.20943.
36. Cunha, C.B., Eduardo, F.P., Zezell, D.M., Bezinelli, L.M., Shitara, P.P., & Correa, L. (2012). Effect of irradiation with red and infrared laser in the treatment of oral mucositis: A pilot study with patients undergoing chemotherapy with 5-FU. Lasers in Medical Science, 27, 1233–1240. doi:10.1007/s10103-012-1089-0.
37. de Castro, J.F., Abreu, E.G., Correia, A.V., Brasil, C.D., da Cruz Perez, D.E., & Pedrosa, F.D. (2013). Low-level laser in prevention and treatment of oral mucositis in pediatric patients with acute lymphoblastic leukemia. Photomedicine and Laser Surgery, 31, 613–618. doi:10.1089/pho.2012.3327.
38. Dodd, M.J., Dibble, S.L., Miaskowski, C., MacPhail, L., Greenspan, D., Paul, S.M., Larson, P. (2000). Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 90, 39–47. doi:10.1067/moe.2000.105713.
39. Dodd, M.J., Miaskowski, C., Greenspan, D., MacPhail, L., Shih, A., Shiba, G., Paul, S.M. (2003). Radiation-induced mucositis: A randomized clinical trial of micronized sucralfate versus salt and soda mouthwashes. Cancer Investigation, 21, 21–33. doi:10.1081/CNV-120016400.
40. Donnelly, J.P., Bellm, L.A., Epstien, J.B., Sonis, S.T., & Symonds, R.P. (2003). Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infectious Diseases, 3, 405–412. doi:10.1016/S1473-3099(03)00668-6.
41. Dorr, W., & Herrmann, T. (2007). Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy: Results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study. Strahlentherapie und Onkologie, 183, 121–127. doi:10.1007/s00066-007-1634-0.
42. Eaton, L.H., & Tipton, J.M. (Eds.). (2009). Mucositis. In Putting Evidence Into Practice: Improving oncology patient outcomes (pp. 193–213). Pittsburgh, PA: Oncology Nursing Society.
43. Eilers, J., Berger, A.M., & Petersen, M.C. (1988). Development, testing, and application of the oral assessment guide. Oncology Nursing Forum, 15, 325–330.
44. Elad, S., Luboshitz-Shon, N., Cohen, T., Wainchwaig, E., Shapira, M.Y., Resnick, I.B., Or, R. (2011). A randomized controlled trial of visible-light therapy for the prevention of oral mucositis. Oral Oncology, 47, 125–130. doi:10.1016/j.oraloncology.2010.11.013.
45. Epstein, J.B., Epstein, J.D., Epstein, M.S., Oien, H., & Truelove, E.L. (2008). Doxepin rinse for management of mucositis pain in patients with cancer: One week follow-up of topical therapy. Special Care in Dentistry, 28, 73–77. doi:10.1111/j.1754-4505.2008.00015.x.
46. Epstein, J.B., Silverman, S., Paggiarino, D.A., Crockett, S., Schubert, M.M., Senzer, N.N., Leveque, F. G. (2001). Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer, 92, 875–885.
47. Ertekin, M.V., Koç, M., Karslioglu, I., & Sezen, O. (2004). Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: A prospective, placebo-controlled, randomized study. International Journal of Radiation Oncology, Biology, Physics, 58, 167–174. doi:10.1016/S0360-3016(03)01562-1.
48. Etiz, D., Erkal, H.S., Serin, M., Küçük, B., Hepari, A., Elhan, A.H., Cakmak, A. (2000). Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. Oral Oncology, 36, 116–120. doi:10.1016/S1368-8375(99)00075-5.
49. Figueiredo, A.L., Lins, L., Cattony, A.C., & Falcão, A.F. (2013). Laser therapy in the control of oral mucositis: A meta-analysis. Revista Da Associacao Medica Brasileira, 59, 467–474. doi:10.1016/j.ramb.2013.08.003.
50. Freytes, C.O., Ratanatharathorn, V., Taylor, C., Abboud, C., Chesser, N., Restrepoo, A., Odenheimer, D. (2004). Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation. Clinical Cancer Research, 10, 8318–8324. doi:10.1158/1078-0432.CCR-04-1118.
51. Gandemer, V., Le Deley, M.C., Dollfus, C., Auvrignon, A., Bonnaure-Mallet, M., Duval, M., Schmitt, C. (2007). Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. Journal of Pediatric Hematology/ Oncology, 29, 86–94. doi:10.1097/MPH.0b013e318030a3e4.
52. Garavito, A.A., Cardona, A.F., Reveiz, L., Ospina, E., Yepes, A., & Ospina, V. (2008). Colchicine mouth washings to improve oral mucositis in patients with hematological malignancies: A clinical trial. Palliative and Supportive Care, 6, 371–376. doi:10.1017/S147895150800059X.
53. Gautam, A.P., Fernandes, D.J., Vidyasagar, M.S., Maiya, A.G., & Vadhiraja, B.M. (2012). Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patientsA triple blinded randomized controlled trial. Radiotherapy and Oncology, 104, 349–354. doi:10.1016/j.radonc.2012.06.011.
54. Gautam, A.P., Fernandes, D.J., Vidyasagar, M.S., & Maiya, G.A. (2012). Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patientsA randomized controlled trial. Oral Oncology, 48, 893–897. doi:10.1016/j.oraloncology.2012.03.008.
55. Genot-Klastersky, M.T., Klastersky, J., Awada, F., Awada, A., Crombez, P., Martinez, M.D., Paesmans, M. (2008). The use of lowenergy laser (LEL) for the prevention of chemotherapy-and/or radiotherapy-induced oral mucositis in cancer patients: Results from two prospective studies. Supportive Care in Cancer, 16, 1381–1387. doi:10.1007/s00520-008-0439-8.
56. Gibson, R.J., Keefe, D.M., Lalla, R.V., Bateman, E., Blijlevens, N., Fijlstra, M., Bowen, J.M. (2013). Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Supportive Care in Cancer, 21, 313–326. doi:10.1007/s00520-012-1644-z.
57. Giles, F.J., Rodriguez, R., Weisdorf, D., Wingard, J.R., Martin, P.J., Fleming, T.R., Hurd, D.D. (2004). A phase III, randomized, double-blind, placebo-controlled study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leukemia Research, 28, 559–565. doi:10.1016/j.leukres.2003.10.021.
58. Gouvêa de Lima, A., Villar, R.C., de Castro, G., Jr., Antequera, R., Gil, E., Rosalmeida, M.C., Snitcovsky, I.M. (2012). Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: A phase III randomized study. International Journal of Radiation Oncology, Biology, Physics, 82, 270–275. doi:10.1016/j.ijrobp.2010.10.012.
59. Harris, D.J., Eilers, J., Harriman, A., Cashavelly, B.J., & Maxwell, C. (2008). Putting Evidence Into Practice: Evidence-based interventions for the management of oral mucositis. Clinical Journal of Oncology Nursing, 12, 141–152. doi:10.1188/08.CJON.141-152.
60. Hawley, P., Hovan, A., McGahan, C.E., & Saunders, D. (2014). A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis. Supportive Care in Cancer, 22, 751–761. doi:10.1007/s00520-013-2031-0.
61. Hejna, M., Köstler, W.J., Raderer, M., Steger, G.G., Brodowicz, T., Scheithauer, W., Zielinski, C.C. (2001). Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: Results of a prospective randomized trial. European Journal of Cancer, 37, 1971–1975. doi:10.1038/sj.bmt.1704521.
62. Henke, M., Alfonsi, M., Foa, P., Giralt, J., Bardet, E., Cerezo, L., Berger, D. (2011). Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: A randomized, placebo-controlled trial. Journal of Clinical Oncology, 29, 2815–2820. doi:10.1200/JCO.2010.32.4103.
63. Hodgson, B.D., Margolis, D.M., Salzman, D.E., Eastwood, D., Tarima, S., Williams, L.D., Whelan, H.T. (2011). Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Supportive Care in Cancer, 20, 1405–1415. doi:10.1007/s00520-011-1223-8.
64. Hogan, R. (2009). Implementation of an oral care protocol and its effects on oral mucositis. Journal of Pediatric Oncology Nursing, 26, 125–135. doi:10.1177/1043454209334356.
65. Hong, J.P., Lee, S.W., Song, S.Y., Ahn, S.D., Shin, S.S., Choi, E.K., & Kim, J.H. (2009). Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies. European Journal of Cancer Care, 18, 636–641. doi:10.1111/j.1365-2354.2008.00971.x.
66. Hunter, A., Mahendra, P., Wilson, K., Fields, P., Cook, G., Peniket, A., Marcus, R. (2009). Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: Results from a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplantation, 43, 563–569. doi:10.1038/bmt.2008.363.
67. Hwang, W.Y., Koh, L.P., Ng, H.J., Tan, P.H., Chuah, C.T., Fook, S.C., Goh, Y.T. (2004). A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 34, 51–56.
68. Jaguar, G.C., Prado, J.D., Nishimoto, I.N., Pinheiro, M.C., de Castro, D.O., Jr., da Cruz Perez, D.E., & Alves, F.A. (2007). Lowenergy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation. Oral Diseases, 13, 538–543. doi:10.1111/j.1601-0825.2006.01330.x.
69. Jahangard-Rafsanjani, Z., Gholami, K., Hadjibabaie, M., Shamshiri, A.R., Alimoghadam, K., Sarayani, A., Ghavamzadeh, A. (2013). The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: A randomized clinical trial. Bone Marrow Transplantation, 48, 832–836. doi:10.1038/bmt.2012.250.
70. Jantunen, E., Kuittinen, T., & Nousiainen, T. (2002). A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients. Leukemia and Lymphoma, 43, 1961–1965. doi:10.1080/1042819021000015907.
71. Jayachandran, S., & Balaji, N. (2012). Evaluating the effectiveness of topical application of natural honey and benzydamine hydrochloride in the management of radiation mucositis. Indian Journal of Palliative Care, 18, 190–195. doi:10.4103/0973-1075.105689.
72. Jensen, S.B., Jarvis, V., Zadik, Y., Barasch, A., Ariyawardana, A., Hovan, A., Elad, S. (2013). Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 3223–3232. doi:10.1007/s00520-013-1884-6.
73. Jham, B.C., Chen, H., Carvalho, A.L., & Freire, A.R. (2009). A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: A secondary analysis. Journal of Oral Science, 51, 565–572. doi:10.2334/josnusd.51.565.
74. Johnson, L.A. (2014). Putting Evidence Into Practice: The process for evidence-based research. Clinical Journal of Oncology Nursing, 18(Suppl.), 2–4. doi:10.1188/14.CJON.S3.2-4.
75. Johnson, L.A., Henry, K.S., Saca-Hazboun, H., & Samuel-Blalock, C. (2014). Mucositis. In M. Irwin & L.A. Johnson (Eds.), Putting Evidence Into Practice: A pocket guide to cancer symptom management (pp. 159–176). Pittsburgh, PA: Oncology Nursing Society.
76. Karagözoglu, S., & Filiz Ulusoy, M.F. (2005). Chemotherapy: The effect of oral cryotherapy on the development of mucositis. Journal of Clinical Nursing, 14, 754–765. doi:10.1111/j.1365-2702.2005.01128.x.
77. Kashiwazaki, H., Matsushita, T., Sugita, J., Shigematsu, A., Kasashi, K., Yamazaki, Y., Inoue, N. (2011). Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Supportive Care in Cancer, 20, 367–373. doi:10.1007/s00520-011-1116-x.
78. Katranci, N., Ovayolu, N., Ovayolu, O., & Sevinc, A. (2012). Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy: A randomized controlled trial. European Journal of Oncology Nursing, 16, 339–344. doi:10.1016/j.ejon.2011.07.008.
79. Kazemian, A., Kamian, S., Aghili, M., Hashemi, F.A., & Haddad, P. (2009). Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: A double-blind placebocontrolled randomized clinical trial. European Journal of Cancer Care, 18, 174–178. doi:10.1111/j.1365-2354.2008.00943.x.
80. Khouri, V.Y., Stracieri, A.B., Rodrigues, M.C., Moraes, D.A., Pieroni, F., Simões, B.P., & Voltarelli, J.C. (2009). Use of therapeutic laser for prevention and treatment of oral mucositis. Brazilian Dental Journal, 20, 215–220. doi:10.1590/S0103-64402009000300008.
81. Khurana, H., Pandey, R.K., Saksena, A.K., & Kumar, A. (2013). An evaluation of vitamin E and pycnogenol in children suffering from oral mucositis during cancer chemotherapy. Oral Diseases, 19, 456–464. doi:10.1111/odi.12024.
82. Kim, K.I., Kim, J.W., Lee, H.J., Kim, B.S., Bang, S.M., Kim, I., Kim, B.K. (2013). Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation. American Journal of Hematology, 88, 107–112. doi:10.1002/ajh.23359.
83. Kono, T., Satomi, M., Chisato, N., Ebisawa, Y., Suno, M., Asama, T., Furukawa, H. (2010). Topical application of hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis. World Journal of Oncology, 1, 232–235. doi:10.4021/wjon263w.
84. Kuhn, A., Porto, F.A., Miraglia, P., & Brunetto, A.L. (2009). Lowlevel infrared laser therapy in chemotherapy-induced oral mucositis: A randomized placebo-controlled trial in children. Journal of Pediatric Hematology/Oncology, 31, 33–37. doi:10.1097/MPH.0b013e318192cb8e.
85. Kwong, K.K. (2004). Prevention and treatment of oropharyngeal mucositis following cancer therapy: Are there new approaches? Cancer Nursing, 27, 183–205. doi:10.1097/00002820-200405000-00003.
86. Lalla, R.V., Gordon, G.B., Schubert, M., Silverman, S., Jr., Hutten, M., Sonis, S.T., Peterson, D.E. (2012). A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Supportive Care in Cancer, 20, 1797–1804. doi:10.1007/s00520-011-1277-7.
87. Lambrecht, M., Mercier, C., Geussens, Y., & Nuyts, S. (2013). The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: A single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care. Supportive Care in Cancer, 21, 2663–2670. doi:10.1007/s00520-013-1829-0.
88. Langner, S., Staber, P.B., Schub, N., Gramatzki, M., Grothe, W., Behre, G., Neumeister, P. (2008). Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplantation, 42, 275–279. doi:10.1038/bmt.2008.157.
89. Le, Q.T., Kim, H.E., Schneider, C.J., Murakozy, G., Skladowski, K., Reinisch, S., Henke, M. (2011). Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: A randomized, placebo-controlled study. Journal of Clinical Oncology, 29, 2808–2814. doi:10.1200/JCO.2010.32.4095.
90. Lilleby, K., Garcia, P., Gooley, T., McDonnnell, P., Taber, R., Holmberg, L., Bensinger, W. (2006). A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 37, 1031–1035. doi:10.1038/sj.bmt.1705384.
91. Lima, A.G., Antequera, R., Gil, E., Peres, M.P., Snitcovsky, I.M., Federucim, M.H., & Villar, R.C. (2010). Efficacy of low level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy induced oral mucositis. Brazilian Dental Journal, 21, 186–192.
92. Lin, L.C., Que, J., Lin, L.K., & Lin, F.C. (2006). Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: A double-blind, randomized study. International Journal of Radiation Oncology, Biology, Physics, 65, 745–750. doi:10.1016/j.ijrobp.2006.01.015.
93. Lin, Y., Lin, L., Lin, S., & Chang, C. (2010). Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: Subgroup analysis of a double-blind, randomized study. Nutrition and Cancer, 62, 682–691. doi:10.1080/01635581003605532.
94. Lockhart, P.B., Brennan, M.T., Kent, M.L., Packman, C.H., Norton, H.J., Fox, P.C., & Frenette, G. (2005). Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplantation, 35, 713–720. doi:10.1038/sj.bmt.1704820.
95. Loo, W.T., Jin, L.J., Chow, L.W., Cheung, M.N., & Wang, M. (2010). Rhodiolaalgida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opinion on Investigational Drugs, 19(Suppl. 1), S91–S100. doi:10.1517/13543781003727057.
96. Lorusso, D., Ferrandina, G., Greggi, S., Gadducci, A., Pignata, S., Tateo, S., Scambia, G. (2003). Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Annals of Oncology, 14, 1086–1093. doi:10.1093/annonc/mdg301.
97. Madan, P.D., Sequeira, P.S., Shenoy, K., & Shetty, J. (2008). The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: A randomized control trial. Journal of Cancer Research Therapies, 4, 3–8. doi:10.4103/0973-1482.39597.
98. Maddocks-Jennings, W., Wilkinson, J.M., Cavanagh, H.M., & Shillington, D. (2009). Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: A randomized, placebo controlled feasibility study. European Journal of Oncology Nursing, 13, 87–93. doi:10.1016/j.ejon.2009.01.002.
99. Maiti, P.K., Ray, A., Mitra, T.N., Jana, U., Bhattacharya, J., & Ganguly, S. (2012). The effect of honey on mucositis induced by chemoradiation in head and neck cancer. Journal of the Indian Medical Association, 110, 453–456.
100. Maiya, G., Sagar, M., & Fernandes, D. (2006). Effect of low level helium-neon (He-Ne) laser therapy in the prevention and treatment of radiation induced mucositis in head and neck cancer patients. Indian Journal of Medical Research, 124, 399–402.
101. Mansouri, A., Hadjibabaie, M., Iravani, M., Shamshiri, A.R., Hayatshahi, A., Javadi, M.R., Ghavamzadeh, A. (2011). The effect of zinc sulfate in the prevention of high-dose chemotherapyinduced mucositis: A double-blind, randomized, placebo-controlled study. Hematological Oncology, 30, 22–26. doi:10.1002/hon.999.
102. Mantovani, G., Massa, E., Astara, G., Murgia, V., Gramignano, G., Lusso, M.R., Macciò, A. (2003). Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs. Oncology Reports, 10, 197–206.
103. Markiewicz, M., Dzierzak-Mietla, M., Frankiewicz, A., Zielinska, P., Koclega, A., Kruszelnicka, M., & Kyrcz-Krzemien, S. (2012). Treating oral mucositis with a supersaturated calcium phosphate rinse: Comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation. Supportive Care in Cancer, 20, 2223–2229. doi:10.1007/s00520-012-1489-5.
104. McAleese, J.J., Bishop, K.M., A’Hern, R., & Henk, J.M. (2006). Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. British Journal of Radiology, 79, 608–613. doi:10.1259/bjr/55190439.
105. McGuire, D.B., Fulton J.S., Park, J., Brown, C.G., Correa, M.E.P., Eilers, J., Lalla, R.V. (2013). Systematic review of basic oral care for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 3165–3177. doi:10.1007/s00520-013-1942-0.
106. Mehdipour, M., Taghavi Zenoz, A., Asvadi Kermani, I., & Hosseinpour, A. (2011). A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis. Daru Journal of Faculty of Pharmacy Tehran University of Medical Sciences, 19, 71–73.
107. Meyer-Hamme, G., Beckmann, K., Radtke, J., Efferth, T., Greten, H.J., Rostock, M., & Schröder, S. (2013). A survey of Chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. Evidence-Based Complementary and Alternative Medicine, 2013, 284959. doi:10.1155/2013/284959.
108. Migliorati, C., Hewson, I., Lalla, R.V., Antunes, H.S., Estilo, C.L., Hodgson, B., Elad, S. (2013). Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 333–341. doi:10.1007/s00520-012-1605-6.
109. Migliorati, C.A., Oberle-Edwards, L., & Schubert, M. (2006). The role of alternative and natural agents, cryotherapy and/or laser for management of alimentary mucositis. Supportive Care in Cancer, 14, 533–540. doi:10.1007/s00520-006-0049-2.
110. Mori, T., Hasegawa, K., Okabe, A., Tsujimura, N., Kawata, Y., Yashima, T., Okamoto, S. (2008). Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation. International Journal of Hematology, 88, 583–587. doi:10.1007/s12185-008-0181-5.
111. Mori, T., Yamazaki, R., Aisa, Y., Nakazato, T., Kudo, M., Yashima, T., Okamoto, S. (2006). Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer, 4, 392–395. doi:10.1007/s00520-005-0016-3.
112. Motallebnejad, M., Akram, S., Moghadamnia, A., Moulana, Z., & Omidi, S. (2008). The effect of topical application of pure honey on radiation-induced mucositis: A randomized clinical trial. Journal of Contemporary Dental Practice, 9, 40–47.
113. Nashwan, A.J. (2011). Use of chlorhexidine mouthwash in children receiving chemotherapy: A review of literature. Journal of Pediatric Oncology Nursing, 28, 295–299. doi:10.1177/1043454211408103.
114. Nasilowska-Adamska, B., Rzepeci, P., Manko, J., Czyz, A., Markieweicz, M., Federowicz, I., Marianska, B. (2007). The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant. Bone Marrow Transplantation, 40, 983–988. doi:10.1038/sj.bmt.1705846.
115. Nes, A.G., & Posso, M.B. (2005). Patients with moderate chemotherapy-induced mucositis: Pain therapy using low intensity lasers. International Nursing Review, 52, 68–72. doi:10.1111/j.1466-7657.2004.00401.x.
116. Nicolatou-Galitis, O., Dardoufas, K., Markoulatos, P., Sotiropoulou-Lontou, A., Kyprianou, K., Kolitsi, G., Velegraki, A. (2001). Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colonystimulating factor (GM-CSF) mouthwash. Journal of Oral Pathology and Medicine, 30, 471–480. doi:10.1034/j.1600-0714.2001.030008471.x.
117. Nicolatou-Galitis, O., Sarri, T., Bowen, J., Di Palma, M., Kouloulias, V.E., Niscola, P., Lalla, R.V. (2013a). Systematic review of amifostine for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 357–364. doi:10.1007/s00520-012-1613-6.
118. Nicolatou-Galitis, O., Sarri, T., Bowen, J., Di Palma, M., Kouloulias, V.E., Niscola, P., Lalla, R.V. (2013b). Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 3179–3189. doi:10.1007/s00520-013-1847-y.
119. Nikoletti, S., Hyde, S., Shaw, T., Myers, H., & Kristjanson, L.J. (2005). Comparison of plain ice and flavored ice for preventing oral mucositis associated with the use of 5 fluorouracil. Journal of Clinical Nursing, 14, 750–753. doi:10.1111/j.1365-2702.2005.01156.x.
120. Niscola, P., Scaramucci, L., Giovannini, M., Ales, M., Bondanini, F., Cupelli, L., de Fabritiis, P. (2009). Palifermin in the management of mucositis in hematological malignancies: Current evidences and future perspectives. Cardiovascular and Hematological Agents in Medicinal Chemistry, 7, 305–312. doi:10.2174/187152509789541873.
121. Nomura, M., Kamata, M., Kojima, H., Hayashi, K., & Sawada, S. (2013). Irsogladine maleate reduces the incidence of fluorouracilbased chemotherapy-induced oral mucositis. Annals of Oncology, 24, 1062–1066. doi:10.1093/annonc/mds584.
122. Nottage, M., McLachlan, S.A., Brittain, M.A., Oza, A., Hedley, D., Feld, R., Moore, M.J. (2003). Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: A randomized, placebo-controlled trial. Supportive Care in Cancer, 11, 41–47. doi:10.1007/s00520-002-0378-8.
123. Panahi, Y., Ala, S., Saeedi, M., Okhovatian, A., Bazzaz, N., & Naghizadeh, M. (2010). Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis. European Journal of Cancer Care, 19, 308–312. doi:10.1111/j.1365-2354.2008.01042.x.
124. Papadeas, E., Naxakis, S., Riga, M., & Kalofonos, C. (2007). Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: A randomized controlled study. European Journal of Oncology Nursing, 11, 60–65. doi:10.1016/j.ejon.2006.05.002.
125. Papas, A.S., Clark, R.E., Martuscelli, G., O’Loughlin, K.T., Johansen, E., & Miller, K.B. (2003). A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplantation, 31, 705–712. doi:10.1038/sj.bmt.1703870.
126. ® improves chemo/ radiotherapy-induced oral mucositis in patients with head and neck cancer: Results of a randomized, placebo-controlled, singleblind Phase II study. Supportive Care in Cancer, 21, 827–834. doi:10.1007/s00520-012-1586-5.
127. Peterson, D.E., Barker, N.P., Akhmadullina, L.I., Rodionova, I., Sherman, N.Z., Davidenko, I.S., Woon, C.W. (2009). Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. Journal of Clinical Oncology, 27, 4333–4338. doi:10.1200/JCO.2008.21.2381.
128. Peterson, D.E., Bensadoun, R.J., Roila, F., & ESMO Guidelines Working Group. (2010). Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Annals of Oncology, 21(Suppl. 5), v261–v265. doi:10.1093/annonc/mdq197.
129. Peterson, D.E., Bensadoun, R.J., Roila, F., & ESMO Guidelines Working Group. (2011). Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Annals of Oncology, 22(Suppl. 6), vi78–vi84. doi:10.1093/annonc/mdr391.
130. Peterson, D.E., Jones, J.B., & Petit, R.G., II. (2006). Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer, 109, 322–331. doi:10.1002/cncr.22384.
131. ® in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck. Journal of Radiotherapy in Practice, 13, 218–225. doi:10.1017/S1460396912000581.
132. Pimenta Amaral, T.M., Campos, C.C., Moreira dos Santos, T.P., Leles, C.R., Teixeira, A.L., Teixeira, M.M., Silva, T.A. (2012). Effect of salivary stimulation therapies on salivary flow and chemotherapy-induced mucositis: A preliminary study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 113, 628–637. doi:10.1016/j.oooo.2011.10.012.
133. Pitten, F.A., Kiefer, T., Buth, C., Doelken, G., & Kramer, A. (2003). Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A doubleblind, block-randomized, controlled study. Journal of Hospital Infection, 53, 283–291. doi:10.1053/jhin.2002.1391.
134. Potting, C.M., Uitterhoeve, R., Op Reimer, W.S., & Van Achterberg, T. (2006). The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: A systematic review. European Journal of Cancer Care, 15, 431–439. doi:10.1111/j.1365-2354.2006.00684.x.
135. Putwatana, P., Sanmanowong, P., Oonprasertpong, L., Junda, T., Pitiporn, S., & Narkwong, L. (2009). Relief of radiation-induced oral mucositis in head and neck cancer. Cancer Nursing, 32, 82–87. doi:10.1097/01.NCC.0000343362.68129.ed.
136. Quinn, B. (2013). Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: A review of current data. European Journal of Cancer Care, 22, 564–579. doi:10.1111/ecc.12073.
137. Qutob, A.F., Gue, S., Revesz, T., Logan, R.M., & Keefe, D. (2013). Prevention of oral mucositis in children receiving cancer therapy: A systematic review and evidence-based analysis. Oral Oncology, 49, 102–107. doi:10.1016/j.oraloncology.2012.08.008.
138. Raber-Durlacher, J.E., von Bültzingslöwen, I., Logan, R.M., Bowen, J., Al-Azri, A.R., Everaus, H., Lalla, R.V. (2013). Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 343–355. doi:10.1007/s00520-012-1594-5.
139. Rao, S., Dinkar, C., Vaishnav, L.K., Rao, P., Rai, M.P., Fayad, R., & Baliga, M.S. (2013). The Indian spice turmeric delays and mitigates radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer: An investigational study. Integrative Cancer Therapies, 13, 201–210. doi:10.1177/1534735413503549.
140. Raphael, M.F., den Boer, A.M., Kollen, W.J., Mekelenkamp, H., Abbink, F.C., Kaspers, G.J., Tissing, W.J. (2014). Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children? Results from a prospective multicenter double blind randomized controlled trial. Supportive Care in Cancer, 22, 3–6. doi:10.1007/s00520-013-2015-0.
141. Rashad, U.M., Al-Gezawy, S.M., El-Gezawy, E., & Azzaz, A.N. (2009). Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. Journal of Laryngology and Otology, 123, 223–228. doi:10.1017/S0022215108002478.
142. Roopashri, G., Jayanthi, K., & Guruprasad, R. (2011). Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail. Contemporary Clinical Dentistry, 2, 8–12. doi:10.4103/0976-237X.79292.
143. Rosen, L.S., Abdi, E., Davis, I.D., Gutheil, J., Schnell, F.M., Zalcberg, J., Clarke, S. (2006). Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. Journal of Clinical Oncology, 24, 5194–5200. doi:10.1200/JCO.2005.04.1152.
144. Rossi, A., Rosati, G., Colarusso, D., & Manzione, L. (2003). Subcutaneous granulocyte–macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fluorouracil plus leucovorin regimen. Oncology, 64, 353–360. doi:10.1159/000070293.
145. Ryu, J.K., Swann, S., LeVeque, F., Scarantino, C.W., Johnson, D., Chen, A., Ang, K.K. (2007). The impact of concurrent granulocyte macrophage-colony stimulating factor on radiationinduced mucositis in head and neck cancer patients: A doubleblind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. International Journal of Radiation Oncology, Biology, Physics, 67, 643–650.
146. Salvador, P., Azusano, C., Wang, L., & Howell, D. (2012). A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. Journal of Pain and Symptom Management, 44, 64–73. doi:10.1016/j.jpainsymman.2011.08.012.
147. Sangthawan, D., Phungrassami, T., & Sinkitjarurnchai, W. (2013). A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients. Journal of the Medical Association of Thailand, 96, 69–76.
148. Satheeshkumar, P.S., Chamba, M.S., Balan, A., Sreelatha, K.T., Bhatathiri, V.N., & Bose, T. (2010). Effectiveness of triclosan in the management of radiation-induced oral mucositis: A randomized clinical trial. Journal of Cancer Research and Therapeutics, 6, 466-472. doi:10.4103/0973-1482.77109.
149. Saunders, D.P., Epstein, J.B., Elad, S., Allemano, J., Bossi, P., van de Wetering, M.D., Lalla, R.V. (2013). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 3191–3207. doi:10.1007/s00520-013-1871-y.
150. Schmidt, E., Thoennissen, N.H., Rudat, A., Bieker, R., Schliemann, C., Mesters, R.M., Berdel, W.E. (2008). Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis. Annals of Oncology, 19, 1644–1649. doi:10.1093/annonc/mdn179.
151. Schubert, M.M., Eduardo, F.P., Guthrie, K.A., Franquin, J., Bensadoun, R.J., Migliorati, C.A., Hamdi, M. (2007). A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Supportive Care in Cancer, 15, 1145–1154. doi:10.1007/s00520-007-0238-7.
152. Sencer, S.F., Zhou, T., Freedman, L.S., Ives, J.A., Chen, Z., Wall, D., Oberbaum, M. (2012). Traumeel S in preventing and treating mucositis in young patients undergoing SCT: A report of the Children’s Oncology Group. Bone Marrow Transplantation, 47, 1409–1414. doi:10.1038/bmt.2012.30.
153. Sharma, A., Rath, G.K., Chaudhary, S.P., Thakar, A., Mohanti, B.K., & Bahadur, S. (2012). Lactobacillus brevis CD2 lozenges reduce radiation-and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebocontrolled study. European Journal of Cancer, 48, 875–881. doi:10.1016/j.ejca.2011.06.010.
154. Shea, T.C., Kewalramani, T., Mun, Y., Jayne, G., & Dreiling, L.K. (2007). Evaluation of single-dose palifermin to reduce oral mucositis in fractionated total-body irradiation and high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation. Journal of Supportive Oncology, 5(Suppl. 2), 60–61.
155. Shih, A., Miaskowski, C., Dodd, M.J., Stotts, N.A., & MacPhail, L. (2002). A research review of the current treatments for radiationinduced oral mucositis in patients with head and neck cancer. Oncology Nursing Forum, 29, 1063–1078. doi:10.1188/02.ONF.1063-1080.
156. Simões, A., Eduardo, F.P., Luiz, A.C., Campos, L., Sá, P.H., Cristófaro, M., Eduardo, C.P. (2009). Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: Comparison between low and high/low power lasers. Lasers in Surgery and Medicine, 41, 264–270. doi:10.1002/lsm.20758.
157. Song, J.J., Twumasi-Ankrah, P., & Salcido, R. (2012). Systematic review and meta-analysis on the use of honey to protect from the effects of radiation-induced oral mucositis. Advances in Skin and Wound Care, 25, 23–28. doi:10.1097/01.ASW.0000410687.14363.a3.
158. Sonis, S.T. (2004). Oral mucositis in cancer therapy. Journal of Supportive Oncology, 2(Suppl. 3), 3–8.
159. Sonis, S.T. (2009). Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evidence, 4, 199–205. doi:10.2147/CE.S5995.
160. Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVegue, F.G., Liggett, W.H., Jr., Mulagha, M.T., Wittes, J.P. (1999). Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer, 85, 2103–2113. doi:10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0.
161. Sorensen, J.B., Skovsgaard, T., Bork, E., Damstrup, L., & Ingeberg, S. (2008). Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil–based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer, 112, 1600–1606. doi:10.1002/cncr.23328.
162. Spencer, A., Horvath, N., Gibson, J., Prince, H.M., Herrmann, R., Bashrod, J., Taylor, K. (2005). Prospective randomized trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplantation, 35, 971–977. doi:1038/sj.bmt.1704946.
163. Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Emmanouilides, C. (2004). Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine, 351, 2590–2598. doi:10.1056/NEJMoa040125.
164. Sprinzl, G.M., Glava, O., deVries, A., Ulmer, H., Gunkel, A.R., Lukas, P., & Thumfart, W.F. (2001). Local application of granulocyte-macrophage colony stimulating factor (GM_CSF) for the treatment of oral mucositis. European Journal of Cancer, 37, 2003–2009. doi:10.1016/S0959-8049(01)00170-8.
165. Steinmann, D., Eilers, V., Beynenson, D., Buhck, H., & Fink, M. (2012). Effect of Traumeel S on pain and discomfort in radiationinduced oral mucositis: A preliminary observational study. Alternative Therapies in Health and Medicine, 18, 12–18.
166. Stokman, M.A., Burlage, F.R., & Spijkervet, F.K. (2012). The effect of a calcium phosphate mouth rinse on (chemo) radiation induced oral mucositis in head and neck cancer patients: A prospective study. International Journal of Dental Hygiene, 10, 175–180. doi:10.1111/j.1601-5037.2012.00574.x.
167. Stokman, M.A., Spijkervet, F.K., Boezen, H.M., Schouten, J.P., Roodenburg, J.L., & deVries, E.G. (2006). Preventive intervention possibilities in radiotherapy and chemotherapy-induced oral mucositis: Results of meta-analysis. Journal of Dental Research, 85, 690–700. doi:10.1177/154405910608500802.
168. Stokman, M.A., Spijkervet, F.K., Burlage, F.R., & Roodenburg, J.L. (2005). Clinical effects of flurbiprofen tooth patch on radiationinduced oral mucositis. A pilot study. Supportive Care in Cancer, 13, 42–48. doi:10.1007/s00520-004-0674-6.
169. Su, C.K., Mehta, V., Ravikumar, L., Shah, R., Pinto, H., Halpern, J., Le, Q.T. (2004). Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiationrelated mucositis in patients with head-and-neck neoplasms. International Journal of Radiation Oncology, Biology, Physics, 60, 171–177. doi:10.1016/j.ijrobp.2004.02.012.
170. Sugita, J., Matsushita, T., Kashiwazaki, H., Kosugi, M., Takahashi, S., Wakasa, K., Imamura, M. (2012). Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD. Bone Marrow Transplantation, 47, 258–264. doi:10.1038/bmt.2011.53.
171. Sung, L., Tomlinson, G.A., Greenberg, M.L., Koren, G., Judd, P., Ota, S., & Feldman, B.M. (2007). Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. European Journal of Cancer, 43, 1269–1275. doi:10.1016/j.eja.2007.02.001.
172. Svanberg, A., Öhrn, K., & Birgegård, G. (2010). Oral cryotherapy reduces mucositis and improves nutritionA randomised controlled trial. Journal of Clinical Nursing, 19, 2146–2151. doi:10.1111/j.1365-2702.2010.03255.x.
173. Thieblemont, V.C., Dumontet, C., Saad, H., Roch, N., Bouafia, F., Arnaud, P., Coiffier, B. (2002). Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. Bone Marrow Transplantation, 30, 769–775. doi:10.1038/sj.bmt.1703757.
174. Tomazevic, T., & Jazbec, J. (2013). A double blind randomized placebo controlled study of propolis (bee glue) effectiveness in the treatment of severe oral mucositis in chemotherapy treated children. Complementary Therapies in Medicine, 21, 306–312. doi:10.1016/j.ctim.2013.04.002.
175. Trotti, A., Garden, A., Warde, P., Symonds, P., Langer, C., Redman, R., Ang, K.K. (2004). A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. International Journal of Radiation Oncology, Biology, Physics, 58, 674–681. doi:10.1016/S0360-3016(03)01627-4.
176. U.S. Department of Health and Human Services. (2010). Common Terminology Criteria for Adverse Events (CTCAE) [v.4.0]. Retrieved from http://1.usa.gov/1wHuEAY.
177. Vadhan-Raj, S., Trent, J., Patel, S., Zhou, X., Johnson, M.M., Araujo, D., Benjamin, R.S. (2010). Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: A randomized trial. Annals of Internal Medicine, 153, 358–367. doi:10.1059/0003-4819-153-6-201009210-00003.
178. Valcarcel, D., Sanz, M.A., Sureda, A., Sala, M., Munoz, L., Subira, M., Sierra, J. (2002). Mouth-washings with recombinant human granulocyte-macrophage colony stimulation factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized, double-blind, placebocontrolled study. Bone Marrow Transplantation, 29, 783–787. doi:10.1038/sj.bmt.1703543.
179. Veness, M.J., Foroudi, F., Gebski, V., Timms, I., Sathiyaseelan, Y., Cakir, B., & Tiver, K.W. (2006). Use of topical misoprostol to reduce radiation-induced mucositis: Results of a randomized, double-blind, placebo-controlled trial. Australasian Radiology, 50, 468–474. doi:10.1111/j.1440-1673.2006.01628.x.
180. Vidal-Casariego, A., Calleja-Fernandez, A., Ballesteros-Pomar, M.D., & Cano-Rodriguez, I. (2013). Efficacy of glutamine in the prevention of oral mucositis and acute radiation-induced esophagitis: A retrospective study. Nutrition and Cancer, 65, 424–429. doi:10.1080/01635581.2013.765017.
181. Vokurka, S., Bystricka, E., Koza, V., Scudlova, J., Pavlicova, V., Valentova, D., Misaniova, L. (2005). The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT— Results of a randomized multicentre study. Supportive Care in Cancer, 13, 554–558. doi:10.1007/s00520-005-0792-9.
182. Vokurka, S., Bystricka, E., Scudlova, J., Mazur, E., Visokaiova, M., Vasilieva, E., Streinerova, K. (2011). The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m2 autologous hematopoietic stem cell transplantation. European Journal of Oncology Nursing, 15, 508–512. doi:10.1016/j.ejon.2011.01.006.
183. Vokurka, S., Skardova, J., Hruskova, R., Kabatova-Maxova, K., Svoboda, T., Bystricka, E., Koza, V. (2011). The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation. Medical Science Monitor, 17, CR572–CR576. doi:10.12659/MSM.881983.
184. von Bültzingslöwen, I., Brennan, M.T., Spijkervet, F.K., Logan, R., Stringer, A., Raber-Durlacher, J.E., & Keefe, D. (2006). Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Supportive Care in Cancer, 14, 519–527. doi:10.1007/s00520-006-0052-7.
185. Ward, E., Smith, M., Henderson, M., Reid, U., Lewis, I., Kinsey, S., Picton, S.V. (2009). The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients. European Journal of Clinical Nutrition, 63, 134–140. doi:10.1038/sj.ejcn.1602894.
186. World Health Organization. (1979). Handbook for reporting results of cancer treatment. Geneva, Switzerland: Author.
187. Worthington, H.V., Clarkson, J.E., Bryan, G., Furness, S., Glenny, A.M., Littlewood, A., Khalid, T. (2011). Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, 9, CD006386. doi:10.1002/14651858.CD000978.pub5.
188. Worthington, H.V., Clarkson, J.E., & Eden, O.B. (2004). Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, 2, CD001973. doi:10.1002/14651858.CD001973.pub2.
189. Wu, H.G., Song, S.Y., Kim, Y.S., Oh, Y.T., Lee, C.G., Keum, K.C., Lee, S.W. (2009). Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial. Cancer, 115, 3699–3708. doi:10.1002/cncr.24414.
190. Yamagata, K., Arai, C., Sasaki, H., Takeuchi, Y., Onizawa, K., Yanagawa, T., Bukawa, H. (2012). The effect of oral management on the severity of oral mucositis during hematopoietic SCT. Bone Marrow Transplantation, 47, 725–730. doi:10.1038/bmt.2011.171.
191. Yarom, N., Ariyawardana, A., Hovan, A., Barasch, A., Jarvis, V., Jensen, S.B., Lalla, R.V. (2013). Systematic review of natural agents for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21, 3209–3221. doi:10.1007/s00520-013-1869-5.
192. Yen, S.H., Wang, L.W., Lin, Y.H., Jen, Y.M., & Chung, Y.L. (2012). Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 82, 1463–1470. doi:10.1016/j.ijrobp.2011.04.029.
193. Yoneda, S., Imai, S., Hanada, N., Yamazaki, T., Senpuku, H., Ota, Y., Uematsu, H. (2007). Effects of oral care on development of oral mucositis and microorganisms in patients with esophageal cancer. Japanese Journal of Infectious Diseases, 60, 23–28.
194. You, W.C., Hsieh, C.C., & Huang, J.T. (2009). Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis. Journal of Alternative and Complementary Medicine, 15, 771–778. doi:10.1089/acm.2008.0322.
195. Zanin, T., Zanin, F., Carvalhosa, A.A., de Souza Castro, P.H., Pacheco, M.T., Zanin, I.C., & Brugnera, A. (2010). Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy. Photomedicine and Laser Surgery, 28, 233–237. doi:10.1089/pho.2008.2242.